Sunovion Pharmaceuticals Inc. Announces FDA Approval of Latuda (lurasidone

Sunovion Pharmaceuticals, Inc. Announces FDA Approval of Latuda (lurasidone ... If LATUDA is prescribed and a moderate inhibitor of CYP3A4 (eg, di...


Sunovion Pharmaceuticals, Inc. Announces FDA Approval of Latuda (lurasidone
If LATUDA is prescribed and a moderate inhibitor of CYP3A4 (eg, diltiazem, atazanavir, erythromycin, fluconazole, verapamil) is added to the therapy, which are reduced to half the original dose LATUDA dose. If a moderate CYP3A4 …
Read more at

Leave a Reply